207 related articles for article (PubMed ID: 31669347)
1. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII.
Guo Y; Wei L; Zhou Y; Lu N; Tang X; Li Z; Wang X
Free Radic Biol Med; 2020 Jan; 146():119-129. PubMed ID: 31669347
[TBL] [Abstract][Full Text] [Related]
2. FV-429 induces apoptosis and inhibits glycolysis by inhibiting Akt-mediated phosphorylation of hexokinase II in MDA-MB-231 cells.
Zhou Y; Lu N; Qiao C; Ni T; Li Z; Yu B; Guo Q; Wei L
Mol Carcinog; 2016 Sep; 55(9):1317-28. PubMed ID: 26258875
[TBL] [Abstract][Full Text] [Related]
3. Gen-27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells.
Tao L; Wei L; Liu Y; Ding Y; Liu X; Zhang X; Wang X; Yao Y; Lu J; Wang Q; Hu R
Biochem Pharmacol; 2017 Feb; 125():12-25. PubMed ID: 27818240
[TBL] [Abstract][Full Text] [Related]
4. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro.
Wang K; Fan H; Chen Q; Ma G; Zhu M; Zhang X; Zhang Y; Yu J
Anticancer Drugs; 2015 Jan; 26(1):15-24. PubMed ID: 25229889
[TBL] [Abstract][Full Text] [Related]
6. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
7. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9.
Li L; Chen P; Ling Y; Song X; Lu Z; He Q; Li Z; Lu N; Guo Q
Eur J Pharm Sci; 2011 Aug; 43(5):393-9. PubMed ID: 21683789
[TBL] [Abstract][Full Text] [Related]
9. Gomisin J inhibits the glioma progression by inducing apoptosis and reducing HKII-regulated glycolysis.
Li R; Yang W
Biochem Biophys Res Commun; 2020 Aug; 529(1):15-22. PubMed ID: 32560813
[TBL] [Abstract][Full Text] [Related]
10. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis.
Zhao L; Li W; Zhou Y; Zhang Y; Huang S; Xu X; Li Z; Guo Q
Free Radic Biol Med; 2015 May; 82():29-41. PubMed ID: 25656992
[TBL] [Abstract][Full Text] [Related]
11. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.
Bryan N; Raisch KP
Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182367
[TBL] [Abstract][Full Text] [Related]
12. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate.
Chen Z; Zhang H; Lu W; Huang P
Biochim Biophys Acta; 2009 May; 1787(5):553-60. PubMed ID: 19285479
[TBL] [Abstract][Full Text] [Related]
13. Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells.
Yang D; Tian X; Ye Y; Liang Y; Zhao J; Wu T; Lu N
Life Sci; 2021 May; 272():119196. PubMed ID: 33617857
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3.
Gimenez-Cassina A; Lim F; Cerrato T; Palomo GM; Diaz-Nido J
J Biol Chem; 2009 Jan; 284(5):3001-3011. PubMed ID: 19033437
[TBL] [Abstract][Full Text] [Related]
15. GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis.
Hu P; Li H; Yu X; Liu X; Wang X; Qing Y; Wang Z; Wang H; Zhu M; Xu J; Tan R; Guo Q; Hui H
Free Radic Biol Med; 2019 Dec; 145():237-249. PubMed ID: 31560953
[TBL] [Abstract][Full Text] [Related]
16. Activation of phospholipase C-γ1 and translocation of phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase contribute to GL-V9-induced apoptosis in human gastric cancer cells.
Zhao K; Li G; Yao Y; Zhou Y; Li Z; Guo Q; Lu N
Exp Cell Res; 2017 Jul; 356(1):8-19. PubMed ID: 28412247
[TBL] [Abstract][Full Text] [Related]
17. Cerulenin-induced apoptosis is mediated by disrupting the interaction between AIF and hexokinase II.
Jeong NY; Yoo YH
Int J Oncol; 2012 Jun; 40(6):1949-56. PubMed ID: 22426850
[TBL] [Abstract][Full Text] [Related]
18. Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells.
Woldetsadik AD; Vogel MC; Rabeh WM; Magzoub M
FASEB J; 2017 May; 31(5):2168-2184. PubMed ID: 28183803
[TBL] [Abstract][Full Text] [Related]
19. Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.
Krasnov GS; Dmitriev AA; Lakunina VA; Kirpiy AA; Kudryavtseva AV
Expert Opin Ther Targets; 2013 Oct; 17(10):1221-33. PubMed ID: 23984984
[TBL] [Abstract][Full Text] [Related]
20. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.
Pastorino JG; Hoek JB; Shulga N
Cancer Res; 2005 Nov; 65(22):10545-54. PubMed ID: 16288047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
